Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.
Alex Zhavoronkov
- Vol. 12, Iss: 8, pp 6492-6510
Reads0
Chats0
TLDR
A review of the limited literature available on geroprotective and senoremediative interventions that may be investigated to decrease the disease burden of gerolavic infections highlights a need for rigorous clinical validation of deep aging clocks as surrogate markers of biological age.Abstract:
The recently identified SARS-CoV-2 betacoronavirus responsible for the COVID-19 pandemic has uncovered the age-associated vulnerability in the burden of disease and put aging research in the spotlight. The limited data available indicates that COVID-19 should be referred to as a gerolavic (from Greek, geros "old man" and epilavis, "harmful") infection because the infection rates, severity, and lethality are substantially higher in the population aged 60 and older. This is primarily due to comorbidity but may be partially due to immunosenescence, decreased immune function in the elderly, and general loss of function, fitness, and increased frailty associated with aging. Immunosenescence is a major factor affecting vaccination response, as well as the severity and lethality of infectious diseases. While vaccination reduces infection rates, and therapeutic interventions reduce the severity and lethality of infections, these interventions have limitations. Previous studies showed that postulated geroprotectors, such as sirolimus (rapamycin) and its close derivative rapalog everolimus (RAD001), decreased infection rates in a small sample of elderly patients. This article presents a review of the limited literature available on geroprotective and senoremediative interventions that may be investigated to decrease the disease burden of gerolavic infections. This article also highlights a need for rigorous clinical validation of deep aging clocks as surrogate markers of biological age. These could be used to assess the need for, and efficacy of, geroprotective and senoremediative interventions and provide better protection for elderly populations from gerolavic infections. This article does not represent medical advice and the medications described are not yet licensed or recommended as immune system boosters, as they have not undergone clinical evaluation for this purpose.read more
Citations
More filters
Journal ArticleDOI
A Geroscience Perspective on COVID-19 Mortality.
TL;DR: The effects of age and sex on mortality rates from COVID-19 mirror the effects of aging on almost all major causes of mortality, and underscore the need to consider the role of basic biological mechanisms of Aging on potential treatment and outcomes of CO VID-19.
Journal ArticleDOI
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.
Dimple Chakravarty,Sujit S. Nair,Nada Hammouda,Parita Ratnani,Yasmine Gharib,Vinayak Wagaskar,Nihal Mohamed,Dara Lundon,Zachary Dovey,Natasha Kyprianou,Ashutosh K. Tewari +10 more
TL;DR: The rapidly emerging data indicating a higher rate of SARS-CoV-2 infection in men are reviewed, and men in the age group most at risk of infection are also at high risk of prostate cancer, and the potential links between these diseases and implications for COVID-19 treatment in prostate cancer patients are explored.
Journal ArticleDOI
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
TL;DR: A systematic review of the available literature on SARS-CoV-2 aims to help readers access the latest knowledge surrounding this new infectious disease and to provide a reference for future studies.
Journal ArticleDOI
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health.
Ícaro Raony,Camila Saggioro de Figueiredo,Pablo Pandolfo,Elizabeth Giestal-de-Araujo,Elizabeth Giestal-de-Araujo,Priscilla Oliveira Silva Bomfim,Priscilla Oliveira Silva Bomfim,Priscilla Oliveira Silva Bomfim,Wilson Savino,Wilson Savino +9 more
TL;DR: The hypothesis that neuroendocrine-immune interactions may be involved in negative impacts of SARS-CoV-2 infection and social isolation on psychiatric issues is highlighted.
Journal ArticleDOI
Frailty and COVID-19: A systematic scoping review
Giuseppe Maltese,Andrea Corsonello,Mirko Di Rosa,Luca Soraci,Cristiana Vitale,Francesco Corica,Fabrizia Lattanzio +6 more
TL;DR: Clinical recommendations on the use of frailty tools have been proposed to support decision making about escalation plan and to improve knowledge of COVID-19 interaction with frailty and to promote patient-centered approaches.
References
More filters
Journal ArticleDOI
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more
TL;DR: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Journal ArticleDOI
The Hallmarks of Aging
TL;DR: Nine tentative hallmarks that represent common denominators of aging in different organisms are enumerated, with special emphasis on mammalian aging, to identify pharmaceutical targets to improve human health during aging, with minimal side effects.
Journal ArticleDOI
DNA methylation age of human tissues and cell types
TL;DR: It is proposed that DNA methylation age measures the cumulative effect of an epigenetic maintenance system, and can be used to address a host of questions in developmental biology, cancer and aging research.
Journal ArticleDOI
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
David E. Harrison,Randy Strong,Zelton D Sharp,James F. Nelson,Clinton M. Astle,Kevin Flurkey,Nancy L. Nadon,J. Erby Wilkinson,Krystyna Frenkel,Christy S. Carter,Christy S. Carter,Marco Pahor,Marco Pahor,Martin A. Javors,Elizabeth Fernandez,Richard A. Miller +15 more
TL;DR: It is reported that rapamycin, an inhibitor of the mTOR pathway, extends median and maximal lifespan of both male and female mice when fed beginning at 600 days of age.
Journal ArticleDOI
The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China
TL;DR: The COVID-19 epidemic has spread very quickly and only took 30 days to expand from Hubei to the rest of Mainland China, with many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic.
Related Papers (5)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more